CoChat

Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21

Possenti, Roberta, Muccioli, Giampiero, Petrocchi, Pamela, Cero, Cheryl, Cabassi, Aderville, Vulchanova, Lucy, Riedl, Maureen S., Manieri, Monia, Frontini, Andrea, Giordano, Antonio, Cinti, Saverio, Govoni, Paolo, Graiani, Gallia, Quaini, Federico, Ghè, Corrado, Bresciani, Elena, Bulgarelli, Ilaria, Torsello, Antonio, Locatelli, Vittorio, Sanghez, Valentina, Larsen, Bjarne D., Petersen, Jorgen S., Palanza, Paola, Parmigiani, Stefano, Moles, Anna, Levi, Andrea, Bartolomucci, Alessandro · 2012 · Biochemical Journal
Cited by 58

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

The peptides encoded by the VGF gene are gaining biomedical interest and are increasingly being scrutinized as biomarkers for human disease. An endocrine/neuromodulatory role for VGF peptides has been suggested but never demonstrated. Furthermore, no study has demonstrated so far the existence of a receptor-mediated mechanism for any VGF peptide. In the present study, we provide a comprehensive in vitro, ex vivo and in vivo identification of a novel pro-lipolytic pathway mediated by the TLQP-21 peptide. We show for the first time that VGF-immunoreactivity is present within sympathetic fibres in the WAT (white adipose tissue) but not in the adipocytes. Furthermore, we identified a saturable receptor-binding activity for the TLQP-21 peptide. The maximum binding capacity for TLQP-21 was higher in the WAT as compared with other tissues, and selectively up-regulated in the adipose tissue of obese mice. TLQP-21 increases lipolysis in murine adipocytes via a mechanism encompassing the activation of noradrenaline/β-adrenergic receptors pathways and dose-dependently decreases adipocytes diameters in two models of obesity. In conclusion, we demonstrated a novel and previously uncharacterized peripheral lipolytic pathway encompassing the VGF peptide TLQP-21. Targeting the sympathetic nerve–adipocytes interaction might prove to be a novel approach for the treatment of obesity-associated metabolic complications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bj20111165

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

8 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 59

  1. Cooke, 2006, The obesity pipeline: current strategies in the development of anti-obesity drugs, Nat. Rev. Drug Discovery, 5, 919, 10.1038/nrd2136 · DOI · Paper page
  2. Cinti, 2005, The adipose organ. Prostaglandins Leukotrienes Essent, Fatty Acids, 73, 9, 10.1016/j.plefa.2005.04.010 · DOI · Paper page
  3. Sethi, 2007, Adipose tissue function and plasticity orchestrate nutritional adaptation, J. Lipid Res., 48, 1253, 10.1194/jlr.R700005-JLR200 · DOI · Paper page
  4. Thompson, 2010, Fatty acid flux in adipocytes: the in's and out's of fat cell lipid trafficking, Mol. Cell. Endocrinol., 318, 24, 10.1016/j.mce.2009.08.015 · DOI · Paper page
  5. Langin, 2006, Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome, Pharmacol. Res., 53, 482, 10.1016/j.phrs.2006.03.009 · DOI · Paper page
  6. Bachman, 2002, βAR signalling required for diet-induced thermogenesis and obesity resistance, Science, 297, 843, 10.1126/science.1073160 · DOI · Paper page
  7. Crowley, 2002, Obesity therapy: altering the energy intake-and-expenditure balance sheet, Nat. Rev. Drug Discovery, 1, 276, 10.1038/nrd770 · DOI
  8. Bartolomucci, 2010, Granins as disease-biomarkers: translational potential for psychiatric and neurological disorders, Neuroscience, 170, 289, 10.1016/j.neuroscience.2010.06.057 · DOI
  9. Levi, 2004, Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor, Cell. Mol. Neurobiol., 24, 517, 10.1023/B:CEMN.0000023627.79947.22 · DOI
  10. Salton, 2000, VGF: a novel role for this neuronal and neuroendocrine polypeptide in the regulation of energy balance, Front. Neuroendocrinol., 21, 199, 10.1006/frne.2000.0199 · DOI · Paper page
  11. Chakraborty, 2006, Quantification of VGF- and pro-SAAS-derived peptides in endocrine tissues and the brain, and their regulation by diet and cold stress, Brain Res., 1089, 21, 10.1016/j.brainres.2006.02.124 · DOI
  12. Hahm, 2002, VGF is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide Y-containing arcuate neurons in response to fasting, J. Neurosci., 22, 6929, 10.1523/JNEUROSCI.22-16-06929.2002 · DOI · Paper page
  13. Hahm, 1999, Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance, Neuron, 23, 537, 10.1016/S0896-6273(00)80806-5 · DOI · Paper page
  14. Bartolomucci, 2006, TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity, Proc. Natl. Acad. Sci. U.S.A., 103, 14584, 10.1073/pnas.0606102103 · DOI · Paper page
  15. Toshinai, 2010, Neuroendocrine regulatory peptide-2 regulates feeding behavior via the orexin system in the hypothalamus, Am. J. Physiol. Endocrinol. Metab., 299, E394, 10.1152/ajpendo.00768.2009 · DOI
  16. Bartolomucci, 2009, Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice, Genes Nutr., 4, 49, 10.1007/s12263-009-0110-0 · DOI
  17. D'Amato, 2008, Differential distribution of VGF-derived peptides in the adrenal medulla and evidence for their selective modulation, J. Endocrinol., 197, 359, 10.1677/JOE-07-0346 · DOI
  18. Rizzi, 2008, The VGF-derived peptide TLQP-21: a new modulatory peptide for inflammatory pain, Neurosci. Lett., 441, 129, 10.1016/j.neulet.2008.06.018 · DOI
  19. Matsuo, 2010, Localization of neuroendocrine regulatory peptide-1 and -2 in human tissues, Regul. Pept., 163, 43, 10.1016/j.regpep.2010.04.007 · doi:10.1016/j.regpep.2010.04.007
  20. Riedl, 2009, Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing, J. Neurosci., 29, 13377, 10.1523/JNEUROSCI.1127-09.2009 · DOI
  21. Vulchanova, 1997, Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals, Neuropharmacology, 36, 1229, 10.1016/S0028-3908(97)00126-3 · DOI · Paper page
  22. Muccioli, 1998, Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland, J. Endocrinol., 157, 99, 10.1677/joe.0.1570099 · DOI · Paper page
  23. Muccioli, 2004, Ghrelin and des-acyl ghrelin both inhibit isoproterenol-induced lipolysis in rat adipocytes via a non-type 1a growth hormone secretagogue receptor, Eur. J. Pharmacol., 498, 27, 10.1016/j.ejphar.2004.07.066 · DOI · Paper page
  24. Student, 1980, Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes, J. Biol. Chem., 255, 4745, 10.1016/S0021-9258(19)85559-X · DOI · Paper page
  25. Petrocchi, 2010, Activation of kinase phosphorylation by heat-shift and mild heat-shock, Cell. Biol. Int. Rep., 17, e00002, 10.1042/CBR20100002 · DOI
  26. Bartolomucci, 2009, Metabolic consequences and vulnerability to diet-induced obesity in male mice under chronic social stress, PLoS ONE, 4, e4331, 10.1371/journal.pone.0004331 · DOI · Paper page
  27. Cinti, 2001, Morphologic techniques for the study of brown adipose tissue and white adipose tissue, Methods Mol. Biol., 155, 21
  28. Emanueli, 1999, Dilated and failing cardiomyopathy in bradykinin B2 receptor knockout mice, Circulation, 100, 2359, 10.1161/01.CIR.100.23.2359 · DOI · Paper page
  29. Graiani, 2005, Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage, Hypertension, 46, 433, 10.1161/01.HYP.0000174986.73346.ba · DOI · Paper page
  30. Costoli, 2004, Effects of chronic psychosocial stress on cardiac autonomic responsiveness and myocardial structure in mice, Am. J. Physiol. Heart. Circ. Physiol., 286, H2133, 10.1152/ajpheart.00869.2003 · DOI · Paper page
  31. Watson, 2009, Analysis of knockout mice suggests a role for VGF in the control of fat storage and energy expenditure, BMC Physiol., 9, 19, 10.1186/1472-6793-9-19 · DOI
  32. Gentile, 2004, The neuroendocrine protein VGF is sorted into dense-core granules and is secreted apically by polarized rat thyroid epithelial cells, Exp. Cell Res., 295, 269, 10.1016/j.yexcr.2004.01.010 · DOI
  33. Possenti, 1999, Expression, processing, and secretion of the neuroendocrine VGF peptides by INS-1 cells, Endocrinology, 140, 3727, 10.1210/endo.140.8.6920 · doi:10.1210/endo.140.8.6920
  34. Giordano, 2005, Regional-dependent increase of sympathetic innervation in rat white adipose tissue during prolonged fasting, J. Histochem. Cytochem., 53, 679, 10.1369/jhc.4A6566.2005 · DOI · Paper page
  35. Omar, 2009, Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis, Cell Signal., 21, 760, 10.1016/j.cellsig.2009.01.015 · DOI · Paper page
  36. Yin, 2003, Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis in 3T3-L1 adipocytes, J. Biol. Chem., 278, 43074, 10.1074/jbc.M308484200 · DOI · Paper page
  37. Cabassi, 2005, Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat, J. Clin. Endocrinol. Metab., 90, 2888, 10.1210/jc.2004-1995 · DOI
  38. Weisberg, 2003, Obesity is associated with macrophage accumulation in adipose tissue, J. Clin. Invest., 112, 1796, 10.1172/JCI200319246 · DOI · Paper page
  39. Xu, 2003, Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, J. Clin. Invest., 112, 1821, 10.1172/JCI200319451 · DOI · Paper page
  40. Brum, 2002, Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice, Am. J. Physiol. Heart. Circ. Physiol., 283, H1838, 10.1152/ajpheart.01063.2001 · DOI
  41. Swynghedauw, 1999, Molecular mechanisms of myocardial remodeling, Physiol. Rev., 79, 215, 10.1152/physrev.1999.79.1.215 · DOI · Paper page
  42. Trani, 2002, Isolation and characterization of VGF peptides in rat brain. Role of PC1/3 and PC2 in the maturation of VGF precursor, J. Neurochem., 81, 565, 10.1046/j.1471-4159.2002.00842.x · DOI
  43. Trani, 1995, Tissue-specific processing of the neuroendocrine protein VGF, J. Neurochem., 65, 2441, 10.1046/j.1471-4159.1995.65062441.x · DOI · Paper page
  44. Su, 2003, Mutational analysis of the hormone-sensitive lipase translocation reaction in adipocytes, J. Biol. Chem., 278, 43615, 10.1074/jbc.M301809200 · DOI · Paper page
  45. Long, 2006, AMP-activated protein kinase signaling in metabolic regulation, J. Clin. Invest., 116, 1776, 10.1172/JCI29044 · DOI · Paper page
  46. Holm, 2000, Molecular mechanisms regulating hormone-sensitive lipase and lipolysis, Annu. Rev. Nutr., 20, 365, 10.1146/annurev.nutr.20.1.365 · DOI · Paper page
  47. Severini, 2008, TLQP-21, a neuroendocrine VGF-derived peptide, prevents cerebellar granule cells death induced by serum and potassium deprivation, J. Neurochem., 104, 534, 10.1111/j.1471-4159.2007.05068.x · DOI
  48. Daval, 2005, Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes, J. Biol. Chem., 280, 25250, 10.1074/jbc.M414222200 · DOI · Paper page
  49. Greenberg, 2001, Stimulation of lipolysis and hormone-sensitive lipase via the extracellular signal-regulated kinase pathway, J. Biol. Chem., 276, 45456, 10.1074/jbc.M104436200 · DOI · Paper page
  50. Gabler, 2008, Increasing intracellular calcium in adipocytes increases fatty acid oxidation via the activation of AMP-activated protein kinase, FASEB J., 22, 147.2, 10.1096/fasebj.22.1_supplement.147.2 · doi:10.1096/fasebj.22.1_supplement.147.2
  51. Garofalo, 1996, Effect of acute cold exposure on norepinephrine turnover rates in rat white adipose tissue, J. Auton. Nerv. Syst., 60, 206, 10.1016/0165-1838(96)00037-9 · DOI
  52. Brito, 2008, Differential sympathetic drive to adipose tissues after food deprivation, cold exposure or glucoprivation, Am. J. Physiol. Regul. Integr. Comp. Physiol., 294, R1445, 10.1152/ajpregu.00068.2008 · DOI · Paper page
  53. Bowers, 2004, Sympathetic innervation of white adipose tissue and its regulation of fat cell number, Am. J. Physiol. Regul. Integr. Comp. Physiol., 286, R1167, 10.1152/ajpregu.00558.2003 · DOI · Paper page
  54. Correll, 1963, Adipose tissue: ability to respond to nerve stimulation in vitro, Science, 140, 387, 10.1126/science.140.3565.387 · DOI · Paper page
  55. Bulló, 2005, Stimulation of NGF expression and secretion in 3T3-L1 adipocytes by prostaglandins PGD2, PGJ2, and Δ12-PGJ2, Am. J. Physiol. Endocrinol. Metab., 289, E62, 10.1152/ajpendo.00008.2005 · DOI
  56. Peeraully, 2004, NGF gene expression and secretion in white adipose tissue: regulation in 3T3-L1 adipocytes by hormones and inflammatory cytokines, Am. J. Physiol. Endocrinol. Metab., 287, E331, 10.1152/ajpendo.00076.2004 · DOI · Paper page
  57. Bartolomucci, 2011, The extended granin family: structure, functions and biomedical implications, Endocr. Rev., 10.1210/er.2010-0027 · DOI · Paper page
  58. Kristiansen, 2004, Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function, Pharmacol. Ther., 103, 21, 10.1016/j.pharmthera.2004.05.002 · DOI · Paper page
  59. Fleenor, 2006, Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I, Horm. Res., 66, 101

Cited by

See all 58

Metadata

Authors
Possenti, R., Muccioli, G., Petrocchi, P., Cero, C., Cabassi, A., Vulchanova, L., Riedl, M. S., Manieri, M., Frontini, A., Giordano, A., Cinti, S., Govoni, P., Graiani, G., Quaini, F., Ghè, C., Bresciani, E., Bulgarelli, I., Torsello, A., Locatelli, V., Sanghez, V., Larsen, B. D., Petersen, J. S., Palanza, P., Parmigiani, S., Moles, A., Levi, A., & Bartolomucci, A.
Affiliations
  • Institute of Cell Biology and Neurobiology, National Research Council and Fondazione Santa Lucia, Rome, Italy
  • Department of Drug Science and Technology, University of Turin, Turin, Italy
  • Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, MN 55455, U.S.A.
  • Department of Internal Medicine, Nephrology and Health Sciences, University of Parma, Parma, Italy
  • Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, MN 55108, U.S.A.
  • Department of Neuroscience, University of Minnesota, Minneapolis, MN 55455, U.S.A.
  • Department of Molecular Pathology, Marche Polytechnic University, Ancona, Italy
  • Department of Experimental Medicine, University of Parma, Parma, Italy
  • Department Internal Medicine, University of Parma, Parma, Italy
  • Department of Experimental Medicine, University of Milano-Bicocca, Monza, Italy
  • Department of Evolutionary and Functional Biology, University of Parma, Parma, Italy
  • Zealand Pharma A/S, Glostrup, Denmark
Venue
Biochemical Journal
Published
2011-12-14
Volume
441
Issue
1
Pages
511-522
ISSN
  • 0264-6021
  • 1470-8728
Cited by
58
References
6
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.